Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0761
D

Failure to Account for and Secure Discontinued Controlled Medication

Sunland, California Survey Completed on 09-11-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

Facility staff failed to ensure that drugs and biologicals were stored in accordance with accepted professional principles, specifically regarding the handling of a discontinued bottle of lorazepam for one resident. The resident, who had multiple diagnoses including metabolic encephalopathy, type 2 diabetes mellitus with hyperglycemia, and was receiving palliative care, had a physician's order for lorazepam oral concentrate to be administered as needed for anxiety over a 14-day period. After the medication was discontinued, the bottle with the original prescription number could not be located during a review of medication records and physical inventory. During interviews and record reviews, it was found that the prescription number on the resident's Individual Count Sheet Record did not match the bottle present in the locked medication room. The Director of Nursing (DON) confirmed that the discontinued lorazepam bottle was not received for safekeeping and was not documented as destroyed according to facility policy. The DON also stated that the medication destruction log did not show that the missing bottle had been destroyed, and the bottle was ultimately unaccounted for. Facility policy requires that discontinued controlled substances be brought to the DON, locked for safekeeping, and destroyed in the presence of the DON and a pharmacist, with proper documentation. The failure of licensed nurses to follow these procedures resulted in the loss of accountability for the controlled medication, as the bottle of lorazepam was not properly secured or disposed of after discontinuation.

An unhandled error has occurred. Reload 🗙